市場調査レポート

商品コード

1633542

鳥インフルエンザワクチンの市場規模シェア、成長分析：ワクチンタイプ別、用途別、株数別、投与経路別、標的種別、流通チャネル別、地域別 - 産業予測、2025年～2032年

Avian Influenza Vaccine Market Size, Share, Growth Analysis, By Vaccine Type, By Application, By Strain, By Administration Route, By Target Species, By Distribution Channel, By Region - Industry Forecast 2025-2032

出版日: 2025年01月12日
発行: SkyQuest
ページ情報: 英文 178 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 3,500 502,495円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 4,400 631,708円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 5,300 760,921円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界の鳥インフルエンザワクチン市場規模は、2023年に1,458億8,000万米ドルと評価され、2024年の1,520億1,000万米ドルから2032年には2,112億5,000万米ドルに成長し、予測期間中（2025～2032年）のCAGRは4.2％で成長する見通しです。

主にH5N1型に起因する鳥インフルエンザは、その起源を水鳥に遡り、中国で最初に検出されたことから、国内の家禽と潜在的な人間の健康の両方に重大なリスクをもたらしています。この病気は世界的に広がる可能性があり、欧州、アジア、南北アメリカの市場に影響を与えます。H5、H7、H9の鳥インフルエンザワクチンは疾病対策に不可欠であり、中国が最大の生産国となっています。同時に米国では、肝硬変は成人人口の0.27％が罹患しており、そのうちの69％は自覚症状がないです。主な危険因子には、糖尿病、アルコール乱用、ウイルス性肝炎が含まれ、この疾患はマッチさせた対照群と比較して死亡率が有意に高いため、公衆衛生上の緊急ニーズが強調されています。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2022-2024）

主要企業プロファイル

Sanofi（France）
GlaxoSmithKline（GSK）（United Kingdom）
Moderna Inc.（United States）
Pfizer Inc.（United States）
AstraZeneca（United Kingdom）
Novavax, Inc.（United States）
Vaxart, Inc.（United States）
BioNTech SE（Germany）
Sinovac Biotech Ltd.（China）
Bharat Biotech International Ltd.（India）
Serum Institute of India Pvt. Ltd.（India）
Daiichi Sankyo Company, Limited（Japan）
Mitsubishi Tanabe Pharma Corporation（Japan）
Seqirus UK Limited（United Kingdom）
Emergent BioSolutions Inc.（United States）
Johnson & Johnson（United States）
Abbott Laboratories（United States）
Roche Holding AG（Switzerland）
Merck & Co., Inc.（United States）

結論と推奨事項

Product Code: SQMIG35A2886

Global Avian Influenza Vaccine Market size was valued at USD 145.88 billion in 2023 and is poised to grow from USD 152.01 billion in 2024 to USD 211.25 billion by 2032, growing at a CAGR of 4.2% during the forecast period (2025-2032).

Avian influenza, primarily driven by the H5N1 strain, poses significant risks to both domestic poultry and potential human health, with its origins traced back to waterfowl and an initial detection in China. The disease has the potential to spread globally, impacting markets across Europe, Asia, and the Americas. Vaccination strategies are crucial; the H5, H7, and H9 avian influenza vaccines are vital in disease control, with China emerging as the largest producer. Concurrently, in the U.S., cirrhosis affects 0.27% of the adult population, with a striking 69% unaware of their condition. Key risk factors include diabetes, alcohol abuse, and viral hepatitis, highlighting urgent public health needs as this condition carries a significantly higher mortality rate compared to matched control groups.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Avian Influenza Vaccine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Avian Influenza Vaccine Market Segmental Analysis

Global Avian Influenza Vaccine Market is segmented by Vaccine Type, Application, Strain, Administration Route, Target Species, Distribution Channel and region. Based on Vaccine Type, the market is segmented into Inactivated Vaccines, Live Recombinant Vaccines, Combination Vaccines, Recombinant Vaccines and Subunit Vaccines. Based on Application, the market is segmented into Chicken, Duck and Goose, Turkey and Others. Based on Strain, the market is segmented into H5 Strain, H7 Strain and H9 Strain. Based on Administration Route, the market is segmented into Intramuscular, Subcutaneous and Waterborne. Based on Target Species, the market is segmented into Broilers, Layers, Breeders and Backyard Poultry. Based on Distribution Channel, the market is segmented into Veterinary Clinics, Online Pharmacies and Retail Stores. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Avian Influenza Vaccine Market

The global avian influenza vaccine market is primarily driven by the escalating incidence of avian influenza, a disease caused by the avian influenza virus type A, predominantly found in waterfowl and transmissible to domestic chickens and various bird species. This virus can be categorized based on its surface proteins into subtypes of neuraminidase (NA) and hemagglutinin (HA), leading to classifications of highly pathogenic and low pathogenicity viruses. Despite nonpathogenic strains typically causing no visible symptoms, highly pathogenic variants pose a significant threat, resulting in severe disease outbreaks and high mortality rates in poultry, thereby underscoring the urgent need for effective vaccination.

Restraints in the Global Avian Influenza Vaccine Market

The Global Avian Influenza Vaccine market faces significant restraints due to the challenges posed by the rapid mutation of the avian influenza virus. This high mutation rate complicates efforts to ensure effective vaccine coverage, as the vaccines may become less effective against emerging strains. Consequently, ongoing research is crucial to comprehend the virus's dynamics and to enhance vaccine formulation and efficacy. As researchers strive to adapt to these viral changes, the demand for innovative solutions in vaccine development becomes increasingly essential, highlighting the need for continuous investment in avian influenza research to bolster public health responses to this ongoing threat.

Market Trends of the Global Avian Influenza Vaccine Market

The Global Avian Influenza Vaccine market is witnessing significant growth, particularly in the Asia-Pacific region, driven by countries like Israel, China, India, and South Korea, which report high incidences of bird flu viruses. The region's increasing focus on enhancing supply chain efficiencies and bolstering research and development through favorable government policies is expected to accelerate vaccine production and distribution. Furthermore, rising awareness around biosecurity measures in poultry farming and the necessity for preventive health strategies further stimulate market demand. This combination of factors is poised to shape a robust market trend, promoting innovation in avian influenza vaccines on a global scale.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Avian Influenza Vaccine Market Size by Vaccine Type & CAGR (2025-2032)

Market Overview
Inactivated Vaccines
Live Recombinant Vaccines
Combination Vaccines
Recombinant Vaccines
Subunit Vaccines

Global Avian Influenza Vaccine Market Size by Application & CAGR (2025-2032)

Market Overview
Chicken
Duck and Goose
Turkey
Others

Global Avian Influenza Vaccine Market Size by Strain & CAGR (2025-2032)

Market Overview
H5 Strain
H7 Strain
H9 Strain

Global Avian Influenza Vaccine Market Size by Administration Route & CAGR (2025-2032)

Market Overview
Intramuscular
Subcutaneous
Waterborne

Global Avian Influenza Vaccine Market Size by Target Species & CAGR (2025-2032)

Market Overview
Broilers
Layers
Breeders
Backyard Poultry

Global Avian Influenza Vaccine Market Size by Distribution Channel & CAGR (2025-2032)

Market Overview
Veterinary Clinics
Online Pharmacies
Retail Stores

Global Avian Influenza Vaccine Market Size & CAGR (2025-2032)

North America (Vaccine Type, Application, Strain, Administration Route, Target Species, Distribution Channel)
- US
- Canada
Europe (Vaccine Type, Application, Strain, Administration Route, Target Species, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Vaccine Type, Application, Strain, Administration Route, Target Species, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Vaccine Type, Application, Strain, Administration Route, Target Species, Distribution Channel)
- Brazil
- Rest of Latin America
Middle East & Africa (Vaccine Type, Application, Strain, Administration Route, Target Species, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Sanofi (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline (GSK) (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Moderna Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novavax, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vaxart, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioNTech SE (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sinovac Biotech Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bharat Biotech International Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Serum Institute of India Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Daiichi Sankyo Company, Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mitsubishi Tanabe Pharma Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seqirus UK Limited (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Emergent BioSolutions Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

鳥インフルエンザワクチンの市場規模シェア、成長分析：ワクチンタイプ別、用途別、株数別、投与経路別、標的種別、流通チャネル別、地域別 - 産業予測、2025年～2032年

Avian Influenza Vaccine Market Size, Share, Growth Analysis, By Vaccine Type, By Application, By Strain, By Administration Route, By Target Species, By Distribution Channel, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

鳥インフルエンザワクチン市場規模：ワクチンタイプ別& CAGR（2025-2032）

鳥インフルエンザワクチン市場規模：用途別& CAGR（2025-2032）

鳥インフルエンザワクチン市場規模：株数別& CAGR（2025-2032）

鳥インフルエンザワクチン市場規模：投与経路別& CAGR（2025-2032）

鳥インフルエンザワクチン市場規模：標的種別& CAGR（2025-2032）

鳥インフルエンザワクチン市場規模：流通チャネル別& CAGR（2025-2032）

鳥インフルエンザワクチン市場規模：地域別& CAGR（2025-2032）